UPDATE: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication (issued November 5, 2019) (2019)

Government Record · U.S. Food and Drug Administration · November 5, 2019

U.S. Food, 2019-11-05: 2019 update to the biotin communication, reporting continuing adverse events from falsely low troponin results and naming assays whose biotin interference risk had not been addressed.

The FDA continues to receive adverse events reports indicating biotin interference caused falsely low troponin results.

First paragraph after 'Date Issued: November 5, 2019'

U.S. Food, 2019-11-05: 2019 update to the biotin communication, reporting continuing adverse events from falsely low troponin results and naming assays whose biotin interference risk had not been addressed. Study type: regulatory record.